New Rejoyn® App For Depression Launched In Great Britain

Otsuka Pharmaceutical Europe Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. (Otsuka) and Click Therapeutics, Inc. (Click) launched their Rejoyn®;app in Great Britain. Rejoyn is the first prescription-only smartphone app in Great Britain for depressive disorder. It is;currently available within select National Health Services of England and Wales (NHS) Trusts, with additional Trusts expected to arrange to use Rejoyn over the next 12 months. ;

Rejoyn was developed in a collaboration between Otsuka and Click Therapeutics. In the U.S., Rejoyn was the first app to be granted clearance for the treatment of major depressive disorder by . . .